Prevention of recurrent HSV-2 disease in guinea pigs immunized with CJ2-gD2.

<p>After challenge with wild-type HSV-2, individual guinea pigs described in the legend of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0101373#pone-0101373-g004" target="_blank">Fig. 4</a> were monitored daily during a 60-day follow-up period for the incidence of genital and disseminated HSV-2 disease. Presented are the cumulative numbers of recurrent lesions per animal (A), number of days that recurrent disease was experienced per animal (B), and the percent of animals that experienced recurrent disease between days 21 to 60 after challenge (C).